Sponsor pipeline

Heronova Pharmaceuticals clinical trial pipeline

Get alerts when Heronova Pharmaceuticals's trials change

3 active trials 3 recruiting 3 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-17
critical
NCT06873555 A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other… · Phase 1/2

Active trials by phase

Phase 1
2
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06873555 A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other… Solid Tumors Recruiting 2026-09-16
Phase 1
NCT07071090 A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid… Solid Tumor Malignancies Recruiting 2026-09-16
NCT07417566 A Study of DC6001 Tablet in Healthy Chinese Adult Subjects Stargardt Disease Recruiting 2026-02-18

Disease areas by active trials

Get alerts when Heronova Pharmaceuticals's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free